HealthCare Global Enterprises holds 28th AGM, adopts FY26 results
- HealthCare Global Enterprises Limited held its 28th AGM on September 18, 2026
- Shareholders adopted audited financial statements for the fiscal year ended March 31, 2026
- Directors Simrun Mehta and Akshay Tanna were reappointed after retiring by rotation
- Related party consultancy agreement with Anjali Ajaikumar Rossi was extended

*this image is generated using AI for illustrative purposes only.
HealthCare Global Enterprises Limited held its 28th Annual General Meeting on September 18, 2026, to transact business including the adoption of audited financial statements for FY26.
The meeting was conducted via video conferencing in compliance with SEBI Listing Regulations and MCA circulars. Dr. B.S. Ajaikumar, Non-Executive Chairman, chaired the proceedings.
Key Resolutions
Shareholders approved the following ordinary and special business items:
- Adoption of audited consolidated financial statements for the year ended March 31, 2026.
- Reappointment of Ms. Simrun Mehta and Mr. Akshay Tanna as directors retiring by rotation.
- Extension of the consultancy agreement with related party Mrs. Anjali Ajaikumar Rossi.
- Ratification of cost auditor remuneration for FY27.
Attendance and Governance
Dr. Manish Mattoo, Executive Director and CEO, presented operational highlights for FY25-26. The board included nine directors, with independent directors chairing audit, nomination, and risk committees.
Eleven members attended the virtual meeting. Five shareholders registered as speakers, with two participating to seek clarifications from management.
Voting Process
Remote e-voting was enabled from September 15 to September 17, 2026. Attendees used Insta-Poll for voting during the meeting. The scrutinizer’s report and final voting results will be filed with stock exchanges separately.
Historical Stock Returns for Healthcare Global Enterprises
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +3.07% | +1.05% | -0.58% | +28.49% | +6.08% | +181.12% |
How will the adoption of FY26 financial results influence HealthCare Global Enterprises' valuation multiples and investor sentiment in the upcoming quarter?
What strategic impact is expected from the extension of the consultancy agreement with Mrs. Anjali Ajaikumar Rossi on the company's operational efficiency and cost structure?
Given the reappointment of key directors, what specific governance or expansion initiatives are likely to be prioritized by the board for the FY27 fiscal year?


































